The bad news is it was on bardoxolone. Tweetorial catch-up here.
The CARDINAL Visual Abstract
Does Bardoxolone help patients with Alport’s Syndrome? Dr M Abdul Qader explains graphically.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies,
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
in this edition: Atacicept in IgAN; Albuminuria as a surrogate outcome, Renal Remission and additional CONFIDENCE analysis
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
The bad news is it was on bardoxolone. Tweetorial catch-up here.
✳️ #TenTweetNephJC ✳️
— Nephrology Journal Club (@NephJC) January 28, 2023
This week CARDINAL - the largest ever RCT in patients with Alport Syndrome 🧵👇 pic.twitter.com/wrAxJoz1GJ
Does Bardoxolone help patients with Alport’s Syndrome? Dr M Abdul Qader explains graphically.